Both etanercept and infliximab can elevate tumor necrosis factor (TNF)-α and be the cause of treatment related new onset disease: The need to measure circulating TNF-α

Richard E. Kast, Eric L. Altschuler

Research output: Contribution to journalLetterpeer-review

3 Scopus citations
Original languageEnglish
Pages (from-to)1679
Number of pages1
JournalJournal of Rheumatology
Issue number8
StatePublished - Aug 2008
Externally publishedYes

Cite this